Testicular Cancer

Jun 25, 2017 by in ONCOLOGY Comments Off on Testicular Cancer

Fig. 12.1 Incidence and number of men diagnosed with testicular cancer, 2000–2012, SEER18, by single year of age and race/ethnicity (Data from United States National Cancer Institute Surveillance, Epidemiology, and…

read more

Conclusions, Perspectives, and Future Considerations

Jun 25, 2017 by in ONCOLOGY Comments Off on Conclusions, Perspectives, and Future Considerations

1. Elucidation of parameters other than age that define the AYA patient 2. Development of and participation in clinical trials benefiting AYA patients 3. Specialization of health services delivery 4….

read more

Acute Myelogenous Leukemia

Jun 25, 2017 by in ONCOLOGY Comments Off on Acute Myelogenous Leukemia

Fig. 6.1 Incidence of acute myelogenous leukemia (AML) by sex and single years of age in children and AYAs (Surveillance, Epidemiology, and End Results, US SEER 18 regions, 2000–2011) Incidence…

read more

Clinical Trials

Jun 25, 2017 by in ONCOLOGY Comments Off on Clinical Trials

Fig. 21.1 Numbers of patients recruited to US cancer trials by 5-year intervals (Personal communication with author) Fig. 21.2 Number of children, teenagers and young adults with newly diagnosed cancer…

read more

Colorectal and Anal Tumors

Jun 25, 2017 by in ONCOLOGY Comments Off on Colorectal and Anal Tumors

Fig. 13.1 Incidence of invasive and in situ malignancy of the colorectum (adenocarcinoma) and the anal canal (squamous cell carcinoma), United States, SEER 2000–2011. In AYAs (inset) incidence increases exponentially…

read more

Health-Related Quality of Life

Jun 25, 2017 by in ONCOLOGY Comments Off on Health-Related Quality of Life

Fig. 30.1 Number of publications per year from January 1994 to December 2013 30.1.3 Patient-Reported Outcome Instruments HRQL is typically measured using Clinical Outcome Assessment (COA) tools, i.e., instruments designed…

read more
Get Clinical Tree app for offline access